Accumulating evidence indicates that ALK activity of EML4-ALK fusion protein mediates tumorigenicity of NSCLC cells via various oncogenic signaling pathways including PI3K/AKT signaling, which is a key regulator of stem-like properties in a cancer stem cell population [17, 28]. Here, EML4 is linked to non-small cell lung carcinoma.